论文部分内容阅读
我们于2012年3月至2013年5月应用前列腺素E1(PGE1)对慢性乙型肝炎肝硬化患者进行治疗,取得了满意的疗效,报告如下。对象与方法 1.一般资料:选择乙型肝炎肝硬化患者85例,男64例,女21例;年龄27~69岁;符合乙型肝炎肝硬化的诊断标准[1],排除合并自身免疫性肝病、酒精性肝病等患者。入组病例分为治疗组43例,对照组
We applied prostaglandin E1 (PGE1) to treat patients with chronic hepatitis B cirrhosis from March 2012 to May 2013 and achieved satisfactory results. The report is as follows. Subjects and methods 1. General information: Select hepatitis B cirrhosis in 85 patients, 64 males and 21 females; aged 27 to 69 years; meet the diagnostic criteria of hepatitis B cirrhosis [1], excluding the combination of autoimmune Liver disease, alcoholic liver disease and other patients. The patients were divided into treatment group 43 cases, control group